A diabetic amputation lawsuit says that a drug manufacturer has not gone far enough to warn patients about the risks of losing a limb. The side effect of amputation can drastically alter a patient’s life.
Plaintiff Carey L. has initiated the diabetic amputation lawsuit based on allegations that the manufacturer of Invokana failed to warn patients about the possible risk of having their limbs amputated as a side effect of using this popular diabetes drug.
The lawsuit says that Johnson & Johnson was involved in failing to disclose the dangerous side effects to the medical community and potential users of Invokana, therefore, putting patients at risk of medical, hospital and surgical expenses, physical pain and suffering, and associated injuries.
The diabetic amputation lawsuit explains that in 2013, the Food and Drug Administration initially approved Invokana as a type-2 diabetes treatment.
However, users of Invokana such as those who filed a diabetic amputation lawsuit, say that the initial labeling and patient safety information included with the drug failed to disclose the dangers of possible amputation in the future.
Once a person develops an infection in their foot or lower extremities, these infections can quickly spread to the bones, leading to a condition known as osteomyelitis.
These infections can also become gangrenous. The only safe medical treatment is amputation after a patient has developed a gangrenous infection.
Since Invokana prevents patients from using a significant portion of the body’s glucose, the body will turn to fat as an alternate source of energy.
This can lead to other challenges such as ketoacidosis. The diabetic amputation lawsuit says that patients should have been told about the dangers of losing a lower extremity because of complications related directly to the drug.
The diabetic amputation lawsuits says that Johnson & Johnson is responsible for failing to include a warning about the increased risks of amputations and many other side effects and has put patients in the unfortunate situation of having to cope with these painful surgeries and the related side effects and the possibility of infection.
The plaintiff in the diabetic amputation lawsuit began taking Invokana in February 2014 to treat diabetes and says that it was ingested as prescribed. In June 2014, that same plaintiff suffered from a trans-metatarsal amputation of the right foot.
The patient says that they should have been told about the dangers of using this medication and how it could increase the chances of amputation in the foot, particularly as it related to the risk of lower extremity amputations.
The diabetic amputation lawsuit says that the development of the injuries was a direct result of the defendant’s failure to properly assess and publicize safety signals, failure to conduct safety studies and the suppression of information related to life threatening risks.
The Diabetic Amputation Lawsuit is Case No. 3:18-cv-10459-BRM-LHG, in the U.S. District Court for the District of New Jersey.
If you’ve suffered severe Invokana side effects, you might have grounds to pursue a diabetic amputation lawsuit with the help of the experienced attorneys at McDonald Worley.
Disclaimer: McDonald Worley is not representing the plaintiff in this lawsuit.